Global auto injectors market is mainly driven by increase in incidence of the life threatening conditions such as anaphylaxis, multiple sclerosis and other food allergies that need an emergency medication. In addition, advancements in auto injectors like introduction of jet injectors, growing home healthcare segment, and increase in demand for the self-injectors expected to bolster the market growth. Furthermore, new formulations, new drug delivery systems, and advancements in targeted drug delivery systems, favourable government policies are expected to boost the auto injectors market. Many biologics are administered as intravenously hence, many manufacturers are adopting auto injectors for the life-saving biologics. However, stringent regulatory requirements, recent product recalls, and presence of substitute products are hampering the global auto injectors market.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-auto-injectors-market/#ulp-4H8Z4LpNMLEuOnnx

Auto injectors market has been segmented based on type, technology, usability, distribution channel, and application

Based on type, auto injectors market is segmented into
Fillable
Pre-Filled

Based on technology, auto injectors market is segmented into
Automated
Manual

Based on usability, auto injectors market is segmented into
Disposable
Reusable

Based on application, auto injectors market is segmented into
Anaphylaxis
Rheumatoid Arthritis
Multiple Sclerosis
Others

Based on distribution channel, auto injectors market is segmented into
Hospitals
Retail Pharmacies
Online Pharmacies
Others

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-auto-injectors-market/#ulp-4H8Z4LpNMLEuOnnx

Auto injector manufacturers are diversifying the product portfolio by introducing low-cost auto injector products, incorporate advanced features into products, and with new product launches. For instance, Mylan N.V. introduced generic version of epipen by reducing the price to half of its original product price. Initial pack of two was sold at US$ 600 until December 2016 that will be sold at US$ 300 from January 2017. Bayer AG introduced betaconnect, an electronic auto injector to treat relapsing-remitting multiple sclerosis in 2016. Companies are actively involved in collaborations, and taking license agreements for auto injector’s technology. In September 2016, Aptar Pharma (AptarGroup, Inc.) collaborated with Becton, Dickinson and Company (BD) to develop auto injector using prefillable syringes from BD and Aptar Pharma’s two-step auto-injector technology.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-auto-injectors-market/#ulp-14mlyhjMGhVjZqa3

Geographically auto injectors market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to be a major market due to prevalence of anaphylaxis, favourable reimbursement policies and increase in healthcare expenditure. In Europe region, growth of auto injectors market is due to consumers shift from hospital based treatment to home care. Countries like China and India have huge growth potential due to increase in healthcare awareness, expenditure and regulatory initiatives to prevent needle stick injuries. However, various initiatives have been taken by World Health Organization (WHO) and regulatory agencies of the countries globally to create healthcare awareness and accelerate the adoption rate of auto-injectors in the Asia-Pacific region. The Middle East and Africa auto injectors market is expected to gain lucrative growth owing to increase in incidences of anaphylaxis and needle stick injuries due to poor healthcare practices in countries like South Africa.

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-auto-injectors-market/

Some of the players in auto injectors market are Becton, Dickinson and Company (U.S), Sanofi (France), Pfizer, Inc. (U.S.), Mylan N.V. (U.S.), Novartis AG (Switzerland), Bayer AG (Switzerland) , Johnson and Johnson Services Inc., (Janssen Global Services) (U.S.), Antares Pharma, Inc. (U.S.), Amgen Inc. (U.S.) and Eli Lilly and Company (U.S) to name a few.

"About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: [email protected]

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

"